# Gentiana lutea

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/gentiana-lutea
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 2 / 10
**Category:** European
**Also Known As:** Great Yellow Gentian, Great Gentian, Bitter Root, Gentian Root, Yellow Gentian, Gentianae radix, European Gentian, Alpine Gentian, Bitterwort, Gall Weed

## Overview

Gentiana lutea (yellow gentian) is a bitter herb whose primary bioactives—iridoid glycosides amarogentin and gentiopicroside—activate bitter taste receptors (TAS2Rs) in the gastrointestinal tract, stimulating gastric acid and bile secretion. This bitter tonic mechanism supports digestive function and appetite, with traditional use validated over 30+ years in European herbal medicine.

## Health Benefits

• Digestive support: Traditional use for mild dyspeptic symptoms and gastrointestinal disorders (evidence: traditional use only, 30+ years in EU)
• Appetite stimulation: Used for temporary loss of appetite through bitter tonic effects (evidence: traditional use only)
• Liver protection: Preclinical studies show [hepatoprotective](/ingredients/condition/detox) effects, suppressing LPS-induced liver injuries at 30-60 mg/kg in animals (evidence: animal studies only)
• [Antioxidant activity](/ingredients/condition/antioxidant): Demonstrated protection against oxidative damage in rat models via catalase and superoxide dismutase modulation (evidence: animal studies only)
• [Antimicrobial](/ingredients/condition/immune-support) properties: Shows activity against bacteria and fungi in laboratory studies (evidence: in-vitro studies only)

## Mechanism of Action

The iridoid glycosides amarogentin and gentiopicroside bind to bitter taste receptors (TAS2R family), particularly TAS2R38 and TAS2R16, expressed on enteroendocrine cells throughout the gastrointestinal mucosa. This binding triggers calcium-mediated signaling cascades that stimulate gastric acid secretion, enhance bile flow from the gallbladder, and promote release of [digestive enzyme](/ingredients/condition/gut-health)s from the pancreas. Preclinical studies also indicate that xanthone derivatives (gentisin, isogentisin) exert [hepatoprotective](/ingredients/condition/detox) effects partly through inhibition of [lipid peroxidation](/ingredients/condition/antioxidant) and modulation of cytochrome P450 enzyme activity.

## Clinical Summary

Human clinical evidence for Gentiana lutea is limited; its EU traditional herbal medicinal product (THMP) status under ESCOP is based on documented traditional use exceeding 30 years rather than randomized controlled trials. Small observational studies and case series support subjective improvements in dyspeptic symptoms such as bloating, nausea, and reduced appetite when standardized root preparations (typically 0.6–2 g dried root or equivalent extracts) are used before meals. Preclinical rodent studies demonstrate [hepatoprotective](/ingredients/condition/detox) and [anti-inflammatory](/ingredients/condition/inflammation) activity of gentian xanthones, though these findings have not been replicated in powered human trials. Overall, evidence is classified as traditional use only, and robust RCT data confirming efficacy for any indication are currently absent.

## Nutritional Profile

Gentiana lutea (Yellow Gentian) root is not consumed as a conventional food source, so macronutrient profiling is limited; however, key compositional data is established: Moisture content in dried root: ~10-12%. Carbohydrates dominate dry weight (~45-50%), primarily as polysaccharides and bitter glycosides. Protein content: ~5-8% dry weight. Fat content: negligible (<1% dry weight). Fiber: ~15-20% dry weight, including structural plant polysaccharides. PRIMARY BIOACTIVE COMPOUNDS (well-characterized): Secoiridoid bitter glycosides — amarogentin (most bitter natural compound known, concentration ~0.05-0.08% dry weight, bitterness value >58,000,000), gentiopicroside/gentiopicrin (dominant bitter compound, ~2-4% dry weight, bitterness value ~12,000), swertiamarin (~0.1-0.5% dry weight), sweroside (~0.1-0.3% dry weight). Xanthone derivatives — gentisin (~0.1-0.2% dry weight), isogentisin, gentisein; these show UV-absorbing and [anti-inflammatory](/ingredients/condition/inflammation) properties. Alkaloids — gentianine and gentianidine (trace levels, <0.05% dry weight). Trisaccharide gentianose (~2-4% dry weight) and disaccharide gentiobiose contribute to carbohydrate fraction. Phenolic acids — caffeic acid, protocatechuic acid (minor concentrations, <0.1% dry weight). MINERALS (root, approximate): Potassium (~1,200-1,800 mg/100g dry weight), Calcium (~400-600 mg/100g), Magnesium (~150-250 mg/100g), Iron (~15-25 mg/100g), Manganese (~8-12 mg/100g), Zinc (~3-5 mg/100g). VITAMINS: Limited data; trace B-vitamins reported but not pharmacologically significant. BIOAVAILABILITY NOTES: Gentiopicroside is well-absorbed orally; peak plasma levels reached within 1-2 hours post-ingestion in animal models. Amarogentin shows lower oral bioavailability due to molecular size but exerts local GI effects. Xanthones exhibit moderate lipophilicity, aiding absorption but subject to first-pass [metabolism](/ingredients/condition/weight-management). Bitter compounds act primarily via local receptor stimulation (TAS2R bitter taste receptors) in the GI tract, so systemic bioavailability is less critical than local concentration. Standardized extracts are typically normalized to 1-4% gentiopicroside content. Typical therapeutic dose of crude root: 0.6-3g/day (Commission E); bitter tonic preparations often dosed at 100-300 mg extract equivalent.

## Dosage & Preparation

Traditional use dosages (no clinical trials available): Comminuted herbal substance 0.5-1 g daily as decoction or infusion; powdered substance 0.5-1 g daily; dry extract (DER 3-5:1, ethanol 30-50% v/v) 0.3-0.6 g daily; liquid extracts (1:10, ethanol 60-70% v/v) 0.3-0.6 ml daily; tinctures (1:5, ethanol 70% v/v) 1-2 ml daily. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Gentiana lutea is generally well tolerated at recommended doses, but high doses may cause nausea, vomiting, and headache due to intense bitter stimulation of the vagus nerve. It is contraindicated in individuals with gastric or duodenal ulcers, gastroesophageal reflux disease (GERD), and known hypersensitivity to Gentianaceae family plants. Because it stimulates gastric acid and bile secretion, it may theoretically potentiate the effects of proton pump inhibitors or H2 blockers, and caution is warranted when combined with anticoagulants given preliminary evidence that gentian xanthones may influence CYP enzyme [metabolism](/ingredients/condition/weight-management). Use during pregnancy and lactation is not recommended due to insufficient safety data.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses are detailed in available sources. The European Medicines Agency (EMA) monographs rely on traditional use rather than well-established clinical evidence, noting at least 30 years of safe application in the EU for digestive indications. All efficacy data comes from preclinical animal models and in-vitro studies.

## Historical & Cultural Context

Used for over 30 years in European traditional medicine for mild digestive disorders and appetite loss, functioning as a bitter stimulant to promote [digestion](/ingredients/condition/gut-health). Historical monographs date to German Kommission E (1985, revised 1990), with the European HMPC establishing an EU traditional use monograph in 2009 (revised 2018).

## Synergistic Combinations

Artichoke leaf extract, Dandelion root, Milk thistle, Peppermint, Ginger root

## Frequently Asked Questions

### What is the standard dosage of Gentiana lutea root?

The ESCOP monograph recommends 0.6–2 g of dried gentian root per dose, typically taken 30 minutes before meals up to three times daily. Liquid extracts (1:1 in 25% ethanol) are dosed at 0.6–2 mL, while tinctures (1:5) are used at 1–3 mL per dose. Standardized preparations are often calibrated to a minimum content of amarogentin or total bitter value (bitterness value ≥10,000 per European Pharmacopoeia standards).

### What are the main active compounds in Gentiana lutea?

The primary bioactives are iridoid secoiridoid glycosides—amarogentin (one of the bitterest natural compounds known, bitterness threshold ~58 ppb) and gentiopicroside—which drive the digestive bitter tonic effects. The root also contains xanthones (gentisin, isogentisin, gentisein) associated with hepatoprotective and anti-inflammatory activity in preclinical models, as well as alkaloids (gentianine, gentialutine) and oligosaccharides (gentianose, gentiobiose).

### Can Gentiana lutea interact with prescription medications?

Gentian xanthones (gentisin, isogentisin) have demonstrated inhibitory effects on cytochrome P450 enzymes, particularly CYP3A4 and CYP1A2, in in vitro studies, which could theoretically raise plasma levels of drugs metabolized by these pathways. Its bile-stimulating effect may alter absorption of fat-soluble drugs, and its gastric acid-stimulating action may counteract antacid or acid-suppression therapy. Patients on anticoagulants, immunosuppressants, or narrow-therapeutic-index drugs should consult a physician before use, as human pharmacokinetic interaction data remain limited.

### Is Gentiana lutea the same as gentian bitters used in cocktails?

Yes, Gentiana lutea root is the primary botanical source of the bitter flavoring in classic cocktail bitters such as Angostura and many aperitifs. The same bitter compounds—amarogentin and gentiopicroside—responsible for medicinal digestive effects are present in these products, though concentrations vary widely and alcoholic bitters are not standardized for therapeutic dosing. For medicinal purposes, pharmacopoeial-grade dried root or standardized extracts are used rather than food-grade alcoholic preparations.

### Who should avoid taking Gentiana lutea supplements?

Individuals with active peptic ulcers, duodenal ulcers, or GERD should avoid gentian root because its bitter stimulation of gastric acid secretion can worsen mucosal irritation and reflux symptoms. It is also contraindicated during pregnancy and breastfeeding due to absence of clinical safety data and the presence of alkaloid constituents (gentianine) with unknown fetal risk. People with known allergy to plants in the Gentianaceae family and those taking medications with a narrow therapeutic index that are metabolized by CYP3A4 should seek medical advice before use.

### What is the difference between Gentiana lutea root extract and whole root powder?

Root extracts concentrate the bitter compounds and active constituents, potentially offering more potent effects per dose compared to whole root powder. Extracts are typically standardized to secoiridoid glycosides (such as gentiopicrin), whereas whole root powder contains the full plant matrix with variable potency depending on growing conditions and harvest timing. Extract forms may be absorbed more efficiently due to their concentrated nature, though both forms have traditional use documented in EU monographs.

### How strong is the clinical evidence supporting Gentiana lutea for digestive health?

Gentiana lutea has been approved by the EMA and included in WHO monographs based on traditional use evidence spanning over 30 years in the European Union, rather than modern clinical trials. Most evidence comes from traditional use data and in vitro studies on its bitter compounds' mechanism of action on digestive secretions, not large-scale randomized controlled trials in humans. While preclinical research suggests digestive support mechanisms, consumers should understand that approval is based on safety and traditional efficacy claims rather than robust clinical trial evidence.

### Is Gentiana lutea safe to use long-term, or is it only meant for short-term digestive support?

Gentiana lutea is traditionally used as a short-term digestive support for mild dyspeptic symptoms and temporary appetite loss, typically taken before meals for limited durations rather than as a daily long-term supplement. The WHO and EMA monographs classify it for traditional use without specific long-term safety data in modern clinical settings, though its historical use spans centuries. Before extending use beyond a few weeks, consultation with a healthcare provider is recommended, particularly for individuals with underlying gastrointestinal conditions or those taking other medications.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*